Concepedia

Tiffany L. Correll

TL

Statistics

Publications

10

Citations

404

H-Index

10

Active since

2005

Affiliations

Amgen (United States)(Current)

Tiffany L. Correll is an author at Amgen (United States) specializing in medicinal chemistry, drug discovery, and pharmacy.

Publications per year

2005–2022

10

Publications

10

Rational Design and Binding Mode Duality of MDM2–p53 Inhibitors

Felix González-López de Turiso, Daqing Sun, Yosup Rew et al. · Journal of Medicinal Chemistry · 2013 · 84 citations · Full text

, , +15

Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles

Yingcai Wang, Jiwen Liu, Paul J. Dransfield et al. · ACS Medicinal Chemistry Letters · 2013 · 81 citations · Full text

, , +17

A highly enantioselective catalyst for asymmetric hydroformylation of [2.2.1]-bicyclic olefins

Jinkun Huang, Emilio E. Bunel, Alan M. Allgeier et al. · Tetrahedron Letters · 2005 · 56 citations

, , +13

Fused Piperidines as a Novel Class of Potent and Orally Available Transient Receptor Potential Melastatin Type 8 (TRPM8) Antagonists

Nuria Tamayo, Yunxin Bo, Vijay Gore et al. · Journal of Medicinal Chemistry · 2012 · 55 citations · Full text

, , +15

Development of a Commercial Manufacturing Process for Sotorasib, a First-in-Class KRAS<sup>G12C</sup> Inhibitor

Liang Zhang, Daniel J. Griffin, Matthew G. Beaver et al. · Organic Process Research & Development · 2022 · 31 citations

, , +14

1–5 of 10